Crinetics Pharmaceuticals stock price
NASDAQ:CRNX · NasdaqCrinetics Pharmaceuticals's chart data is dated 2026-09-02. Recorded technical signals: 52-week high, MA aligned. There are 20 published signal records.
Crinetics Pharmaceuticals last closed at $84.95 (+0.00%) on 2026-09-02. Signals today: 52-week high, MA aligned. Listed on Nasdaq. The display ticker is CRNX. The trading market is Nasdaq.
About this company
Crinetics Pharmaceuticals last closed at $84.95 (+0.00%) on 2026-09-02. Signals today: 52-week high, MA aligned. Listed on Nasdaq.
Details →Reported results
Position in sector
No overall sector grade is available.
No valuation grade is available.
Related stocks
- NovartisCompetitor
희귀질환·내분비 분야에서 Crinetics의 파이프라인과 경쟁하는 글로벌 제약사
- PfizerCompetitor
내분비·희귀질환 치료제 개발/상업화에서 경쟁 가능한 대형 제약사
- AmgenCompetitor
희귀질환 및 전문의약품 시장에서 경쟁 가능한 글로벌 바이오/제약사
ETFs holding this stock
ALPS Medical Breakthroughs ETF · SPDR S&P Pharmaceuticals ETF · Virtus LifeSci Biotech Products ETF
Details →About Crinetics Pharmaceuticals
- What technical signals does Crinetics Pharmaceuticals (CRNX) have?
- Crinetics Pharmaceuticals current technical signals: MA alignment (score 0.97).
- Is Crinetics Pharmaceuticals a cup-and-handle pattern?
- No. Crinetics Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for Crinetics Pharmaceuticals?
- Market cap: $8.06B. Last annual report PBR: 6.08×.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Crinetics Pharmaceuticals, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.